Atlas Trials

Study to Evaluate Safety, Tolerability and Immunogenicity of Vaccine (UB 311) in Subjects With Alzheimer's Disease

Clinical trial NCT00965588 · COMPLETED

Trial details

NCT number
NCT00965588
Sponsor
United Biomedical
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2009-02-01
Primary completion
2011-04-01
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.